mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.008 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.009 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.009 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.02 |